Estey E - Search Results

1

Treatment of newly diagnosed acute promyelocytic leukemia without cytarabine.

Estey E, Thall PF, Pierce S, Kantarjian H, Keating M. Estey E, et al. J Clin Oncol. 1997 Feb;15(2):483-90. doi: 10.1200/JCO.1997.15.2.483. J Clin Oncol. 1997. PMID: 9053469 Clinical Trial.

2

Treatment of newly diagnosed acute myelogenous leukemia with granulocyte-macrophage colony-stimulating factor (GM-CSF) before and during continuous-infusion high-dose ara-C + daunorubicin: comparison to patients treated without GM-CSF.

Estey E, Thall PF, Kantarjian H, O'Brien S, Koller CA, Beran M, Gutterman J, Deisseroth A, Keating M. Estey E, et al. Blood. 1992 May 1;79(9):2246-55. Blood. 1992. PMID: 1571541 Free article.

3

Mitoxantrone and high-dose etoposide for patients with relapsed or refractory acute leukemia.

O'Brien S, Kantarjian H, Estey E, Koller C, Beran M, McCredie K, Keating M. O'Brien S, et al. Among authors: estey e. Cancer. 1991 Aug 15;68(4):691-4. doi: 10.1002/1097-0142(19910815)68:4<691::aid-cncr2820680404>3.0.co;2-z. Cancer. 1991. PMID: 1855168

4

Response to salvage therapy and survival after relapse in acute myelogenous leukemia.

Keating MJ, Kantarjian H, Smith TL, Estey E, Walters R, Andersson B, Beran M, McCredie KB, Freireich EJ. Keating MJ, et al. Among authors: estey e. J Clin Oncol. 1989 Aug;7(8):1071-80. doi: 10.1200/JCO.1989.7.8.1071. J Clin Oncol. 1989. PMID: 2666590

5

Patient-specific dose rate for continuous infusion high-dose cytarabine in relapsed acute myelogenous leukemia.

Heinemann V, Estey E, Keating MJ, Plunkett W. Heinemann V, et al. Among authors: estey e. J Clin Oncol. 1989 May;7(5):622-8. doi: 10.1200/JCO.1989.7.5.622. J Clin Oncol. 1989. PMID: 2709090

6

Comparison of results of salvage therapy in adult acute myelogenous leukemia.

Keating MJ, Estey E, Kantarjian HM, Walters R, Smith T, McCredie KB, Freireich EJ. Keating MJ, et al. Among authors: estey e. Acta Haematol. 1987;78 Suppl 1:120-6. doi: 10.1159/000205916. Acta Haematol. 1987. PMID: 3124434

7

Use of granulocyte colony-stimulating factor before, during, and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes: comparison with fludarabine plus cytarabine without granulocyte colony-stimulating factor.

Estey E, Thall P, Andreeff M, Beran M, Kantarjian H, O'Brien S, Escudier S, Robertson LE, Koller C, Kornblau S, et al. Estey E, et al. J Clin Oncol. 1994 Apr;12(4):671-8. doi: 10.1200/JCO.1994.12.4.671. J Clin Oncol. 1994. PMID: 7512125 Clinical Trial.

8

Cytogenetic and clinical correlates in AML patients with abnormalities of chromosome 16.

Marlton P, Keating M, Kantarjian H, Pierce S, O'Brien S, Freireich EJ, Estey E. Marlton P, et al. Among authors: estey e. Leukemia. 1995 Jun;9(6):965-71. Leukemia. 1995. PMID: 7596186

9

Granulocyte colony-stimulating factor supportive treatment following intensive chemotherapy in acute lymphocytic leukemia in first remission.

Kantarjian HM, Estey E, O'Brien S, Anaissie E, Beran M, Pierce S, Robertson L, Keating MJ. Kantarjian HM, et al. Among authors: estey e. Cancer. 1993 Nov 15;72(10):2950-5. doi: 10.1002/1097-0142(19931115)72:10<2950::aid-cncr2820721015>3.0.co;2-b. Cancer. 1993. PMID: 7693325

10

Clinical and prognostic significance of trisomy 21 in adult patients with acute myelogenous leukemia and myelodysplastic syndromes.

Cortes JE, Kantarjian H, O'Brien S, Keating M, Pierce S, Freireich EJ, Estey E. Cortes JE, et al. Among authors: estey e. Leukemia. 1995 Jan;9(1):115-7. Leukemia. 1995. PMID: 7845005

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

743 results

Search Page

Filters